Preclinical News and Research

RSS
Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

Dimerix Bioscience announces research agreement with Takeda Cambridge

Dimerix Bioscience announces research agreement with Takeda Cambridge

Statin use may increase risk of developing benign colorectal tumors: APC trial

Statin use may increase risk of developing benign colorectal tumors: APC trial

Momenta Pharmaceuticals presents preclinical data of M402 at AACR 2010

Momenta Pharmaceuticals presents preclinical data of M402 at AACR 2010

Cornerstone Pharmaceuticals obtains clearance for CPI-613 human clinical trial for hematologic malignancies

Cornerstone Pharmaceuticals obtains clearance for CPI-613 human clinical trial for hematologic malignancies

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals

Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010

Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Endra Life Sciences launches Nexus 128 preclinical photoacoustic CT scanner

Endra Life Sciences launches Nexus 128 preclinical photoacoustic CT scanner

Repligen expects total revenue of $21.0M for fiscal year 2010

Repligen expects total revenue of $21.0M for fiscal year 2010

VisEn Medical expands FMT imaging platform

VisEn Medical expands FMT imaging platform

Investment report on Idenix Pharmaceuticals

Investment report on Idenix Pharmaceuticals

Pharmacyclics to present on Btk and HDAC programs at AACR 2010

Pharmacyclics to present on Btk and HDAC programs at AACR 2010

Preclinical results of Avila Therapeutics' AVL-181 and AVL-192 presented at EASL Annual Meeting

Preclinical results of Avila Therapeutics' AVL-181 and AVL-192 presented at EASL Annual Meeting

New nanotechnology biomedical therapy for joint injuries

New nanotechnology biomedical therapy for joint injuries

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.